Keywords: Kinex Pharma, PharmaEssentia, KX01, Dermatology drug candidate, Psoriasis, Asian territories

PharmaEssentia gets certain Asian rights to Kinex' dermatology candidate KX01

Article | 03 December 2012

USA-based privately-held Kinex Pharmaceuticals has entered a licensing agreement granting Taiwan’s PharmaEssentia exclusive rights in certain Asian territories ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

PharmaEssentia

Kinex Pharmaceuticals

Go to company listing

Related Drugs

KX01

Go to drug listing